Aquestive Therapeutics (AQST) Market Capitalization (2018 - 2026)

Aquestive Therapeutics has reported Market Capitalization for 9 years, with the latest figure at $522.1 million in Q2 2026.

• On a quarterly basis, Market Capitalization rose 58.77% year-over-year to $522.1 million in Q2 2026; TTM through Jun 2026 was $522.1 million, a 58.77% increase from a year earlier, with the FY2025 full-year figure at $788.4 million, up 142.26% from the prior year.
• Market Capitalization was $522.1 million for Q2 2026 at Aquestive Therapeutics, up from $515.8 million in the prior quarter.
• The five-year high for Market Capitalization was $788.4 million in Q4 2025, with the low at $34.1 million in Q2 2022.
• Average Market Capitalization over 5 years is $284.1 million, with a median of $262.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Market Capitalization slumped 77.71% in 2022, then surged 391.91% in 2024.
• Over 5 years, Market Capitalization stood at $49.5 million in 2022, then soared by 179.9% to $138.4 million in 2023, then soared by 135.08% to $325.4 million in 2024, then jumped by 142.26% to $788.4 million in 2025, then slumped by 33.77% to $522.1 million in 2026.
• The last three Market Capitalization figures came in at $522.1 million (Q2 2026), $515.8 million (Q1 2026), and $788.4 million (Q4 2025), per Business Quant data.